(Q44648444)

5 December 2017

title

Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure (English)

1 reference

Cardiology and cardiovascular medicine

5 December 2017

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00162-4

30 March 2024

author name string

Akira Matsumori

1

1 reference

5 December 2017

Assessment of Response to Candesartan in Heart Failure in Japan (ARCH-J) Study Investigators

2

1 reference

5 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607207

30 March 2024

publication date

1 October 2003

1 reference

full work available at URL

5 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/S1388-9842%2803%2900162-4

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607207

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS1388-9842(03)00162-4

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00162-4

https://onlinelibrary.wiley.com/doi/pdf/10.1016/S1388-9842%2803%2900162-4

30 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00162-4

European Journal of Heart Failure

30 March 2024

published in

1 reference

5 December 2017

volume

5

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

669-677

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Medical advances in the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Achieving Quality 24-h Blood Pressure Control with Candesartan Cilexetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900162-4

Economic impact of heart failure in the United States: time for a different approach

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00162-4

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/S1388-9842(03)00162-4

30 March 2024

Identifiers

1 reference

5 December 2017

1 reference